Kira Wahlstedt-Lindström
Direttore Finanziario/CFO presso Forendo Pharma Oy
Provenienza dei contatti di primo grado di Kira Wahlstedt-Lindström
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kira Wahlstedt-Lindström tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Hormos Medical Oy
Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
Sunstone LSV General Partner I ApS | Corporate Officer/Principal | ||
FBC Device ApS
FBC Device ApS Medical SpecialtiesHealth Technology FBC Device ApS provides spinal implants for the treatment of degenerative disc disease. Its products include Statur-L. The firm develops and manufactures healthcare equipment that helps in the placement of spine in correct position after an implant surgery. The company was founded by Finn Bjarke Christensen in 2005 and is headquartered in Risskov, Denmark. | Medical Specialties | Director/Board Member | |
The International Venture Club | Corporate Officer/Principal | ||
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member | |
Sunstone LSV Management A/S | Director/Board Member | ||
Parsimoneous Holding ApS
Parsimoneous Holding ApS Financial ConglomeratesFinance Parsimoneous Holding ApS functions as an investment holding Danish company. The private company is based in Gentofte, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Latentix ApS
Latentix ApS Information Technology ServicesTechnology Services Latentix ApS provides custom computer programming services. The private company is based in Frederiksberg, Denmark. | Information Technology Services | Corporate Officer/Principal | |
Sunstone LSV General Partner BI ApS | Corporate Officer/Principal | ||
Sunstone Lsv Special Ltd. Partner Iii Holding Aps | Chief Executive Officer | ||
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
Sunstone Tv Lsv Special LP Ill Aps
Sunstone Tv Lsv Special LP Ill Aps Financial ConglomeratesFinance Sunstone Tv Lsv Special LP Ill Aps is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone LSV Invest III Holding ApS | Chief Executive Officer | ||
Sunstone LSV Special Limited Partner III Aps | Chief Executive Officer | ||
Sunstone LSV General Partner Ill ApS
Sunstone LSV General Partner Ill ApS Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone LSV General Partner Ill ApS functions as an investment holding Danish company. The company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone LSV Invest III ApS | Chief Executive Officer | ||
Abinitio ApS
Abinitio ApS Financial ConglomeratesFinance Abinitio ApS is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone Lsv General Partner Ii ApS
Sunstone Lsv General Partner Ii ApS Financial ConglomeratesFinance Sunstone Lsv General Partner Ii ApS functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Sunstone LSV Partners & Co. Holding III ApS | Chief Executive Officer | ||
FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Sunstone Lsv & Co. Invest Ill Holding Aps
Sunstone Lsv & Co. Invest Ill Holding Aps Financial ConglomeratesFinance Sunstone Lsv & Co. The private company is based in Copenhagen, Denmark. Invest Ill Holding Aps functions as an investment holding Danish company. | Financial Conglomerates | Chief Executive Officer | |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
CUTISS AG
CUTISS AG Medical SpecialtiesHealth Technology CUTISS AG develops bioengineered skin grafts to heal people with skin defects. The company was founded by Ernst Reichmann, Martin Meuli, Daniela Marino, Clemens Schiestl and Fabienne Hartmann-Fritsch and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
Arctos Medical AG
Arctos Medical AG BiotechnologyHealth Technology Arctos Medical AG engages in the acquisition, development, holding, registration, management, disposal, and exploitation of intellectual property rights and similar assets in the medical sector. These include patents, trademarks, licenses, industrial property rights, and inventions. The company was founded on June 6, 2012 and is headquartered in Bern, Switzerland. | Biotechnology | Director/Board Member | |
SENSIRION HOLDING AG | Semiconductors | Director/Board Member | |
Swiss National Science Foundation | Corporate Officer/Principal | ||
Ludwig-Maximilians-Universität München | College/University | Graduate Degree | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
University of Copenhagen | College/University | Graduate Degree | |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Investment Managers | Private Equity Investor | |
Radiometer Medical ApS
Radiometer Medical ApS Medical SpecialtiesHealth Technology Part of Danaher Corp., Radiometer Medical ApS is a Danish company that develops, manufactures, and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems. The company is based in Brønshøj, Denmark. The company's solutions enable the assessment of wounds and vascular disease, particularly Peripheral Artery Disease, and provide streamlined quality control data management and compliance. The company's AQURE POC IT solution offers a complete overview and centralized control of point-of-care testing setups, including quality control management, device and operator competency management, and sample workflow safeguarding. Radiometer Medical was founded in 1935 by Carl Schrøder and Børge Aagaard. | Medical Specialties | Corporate Officer/Principal | |
ACARIX AB | Medical Specialties | Director/Board Member | |
Humboldt-Universität zu Berlin | College/University | Doctorate Degree | |
Life Science Ventures
Life Science Ventures Investment ManagersFinance Life Science Ventures provides financial advice. | Investment Managers | Corporate Officer/Principal | |
Sunstone LSV Partners Holding III ApS | Chief Executive Officer | ||
Sunstone LSV & Co. Special Limited Partner III Holding ApS | Chief Executive Officer | ||
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Livingston International, Inc.
Livingston International, Inc. Air Freight/CouriersTransportation Livingston International, Inc. engages in provision of customs brokerage, transportation and integrated logistics services. Its services include customs brokerage, U.S. customs brokerage, Canadian customs brokerage, Mexican customs brokerage, freight and transportation, global trade management, trade consulting, trade technology, business process services, trade sphere and vehicle transportation services. The company was founded by Gerry Livingston in 1945 and is headquartered in Toronto, Canada. | Air Freight/Couriers | Director/Board Member | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Investments | |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Danimarca | 34 |
Svezia | 5 |
Svizzera | 5 |
Germania | 4 |
Regno Unito | 3 |
Settori
Health Technology | 19 |
Finance | 10 |
Consumer Services | 5 |
Distribution Services | 3 |
Electronic Technology | 3 |
Posizioni
Director/Board Member | 114 |
Corporate Officer/Principal | 29 |
Chief Executive Officer | 20 |
Chairman | 15 |
Founder | 8 |
Contatti più connessi
Insiders | |
---|---|
Viktor Drvota | 41 |
Claus Asbjørn Andersson | 41 |
Stéphane Verdood | 32 |
Søren Møller | 21 |
Anja Koenig | 19 |
Hakan Goker | 18 |
Risto Arvo Sakari Lammintausta | 7 |
Lauri Kangas | 2 |
Pasi Koskimies | 1 |
- Borsa valori
- Insiders
- Kira Wahlstedt-Lindström
- Connessioni Società